• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

    5/24/24 8:22:48 AM ET
    $AKAN
    $AKTS
    $BIOR
    $BNED
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKAN alert in real time by email

    Shares of Ross Stores, Inc. (NASDAQ:ROST) rose sharply in today's pre-market trading after the company reported better-than-expected earnings for its first quarter and increased its profit forecast for the year.

    The company posted quarterly revenue of $4.858 billion, versus estimates of $4.833 billion. Earnings came in at $1.46 per share, versus estimates of $1.34 per share, according to data from Benzinga Pro.

    Ross Stores shares jumped 8.2% to $142.73 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Netcapital Inc. (NASDAQ:NCPL) rose 105.2% to $0.3587 in today's pre-market trading after jumping 15% on Thursday.
    • Akanda Corp. (NASDAQ:AKAN) shares gained 99.2% to $4.76 in pre-market trading after dipping 35% on Thursday.
    • Cue Health Inc. (NASDAQ:HLTH) gained 36.4% to $0.1288 in pre-market trading after falling around 12% on Thursday. Cue Health, last week, announced that it voluntarily and temporarily paused sales and distribution of its EUA COVID-19 Test Cartridge.
    • Verastem, Inc. (NASDAQ:VSTM) gained 35.3% to $16.48 in pre-market trading. Verastem Oncology disclosed positive initial interim safety and efficacy results from RAMP 205 trial evaluating avutometinib plus defactinib in combination with gemcitabine and nab-paclitaxel in first-line metastatic pancreatic cancer​.
    • Nuburu, Inc. (NYSE:BURU) shares rose 26.8% to $0.1759 in pre-market trading.
    • Blue Star Foods Corp. (NASDAQ:BSFC) shares gained 24.8% to $3.13 in pre-market trading. The company, earlier during the week, reported first-quarter financial results.
    • Candel Therapeutics, Inc. (NASDAQ:CADL) shares climbed 19.2% to $12.74 in pre-market trading. Candel Therapeutics reported prolonged overall survival in Phase 2 clinical trial of CAN-2409 for Advanced Non-Small Cell Lung Cancer (NSCLC) in patients non-responsive to Immune Checkpoint Inhibitor (ICI) treatment at 2024 ASCO Annual Meeting.
    • OneMedNet Corporation (NASDAQ:ONMD) gained 17% to $1.72 in pre-market trading. OneMedNet shares jumped 208% on Thursday after the company highlighted a ‘five-fold expansion’ of its iRWD network and platform.
    • Biora Therapeutics, Inc. (NASDAQ:BIOR) gained 12.3% to $0.5579 in pre-market trading after tumbling 28% on Thursday.

    Losers

    • Soluna Holdings, Inc. (NASDAQ:SLNH) shares declined 43.7% to $1.40 in pre-market trading after dipping 6% on Thursday.
    • Sensei Biotherapeutics, Inc.. (NASDAQ:SNSE) shares declined 31.5% to $1.00 in pre-market trading. Sensei Biotherapeutics presented clinical data from Phase 1 dose escalation study of SNS-101.
    • Barnes & Noble Education, Inc. (NYSE:BNED) shares dipped 24.1% to $0.60 in pre-market trading after the company reported preliminary FY24 consolidated revenue of approximately $1.567 billion.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) shares fell 21.2% to $3.40 in pre-market trading.
    • Akoustis Technologies, Inc. (NASDAQ:AKTS) shares fell 15.8% to $0.1765 in pre-market trading after dipping 33% on Thursday. Akoustis recently announced a $10 million registered direct offering priced at-the-market under Nasdaq rules.
    • Pineapple Energy Inc. (NASDAQ:PEGY) shares fell 13.7% to $0.2090 in pre-market trading after jumping 61% on Thursday.
    • Phoenix Motor Inc (NASDAQ:PEV) shares fell 13% to $0.62 in pre-market trading. Phoenix Motor said it has rescheduled its first quarter 2024 earnings call to Thursday, May 30, at 4:30 p.m. ET.
    • Roadzen Inc (NASDAQ:RDZN) fell 12.6% to $3.36 in pre-market trading.
    • Workday, Inc. (NASDAQ:WDAY) shares declined 12.4% to $228.48 in pre-market trading. Workday posted upbeat earnings for its first quarter. However, the company lowered its forward guidance and now sees second-quarter subscription revenue of $1.895 billion and fiscal-year subscription revenue of between $7.7 billion and $7.725 billion.
    • Intuit Inc. (NASDAQ:INTU) shares fell 6.3% to $620.82 in pre-market trading. Intuit posted better-than-expected earnings for its third quarter and boosted its full-year outlook. However, the company issued weak earnings guidance for the current quarter.

    Now Read This: SLB, First Solar And 2 Other Stocks Insiders Are Selling

    Get the next $AKAN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKAN
    $AKTS
    $BIOR
    $BNED

    CompanyDatePrice TargetRatingAnalyst
    Ross Stores Inc.
    $ROST
    3/4/2026$220.00 → $240.00Market Perform → Outperform
    Telsey Advisory Group
    Intuit Inc.
    $INTU
    2/27/2026$624.00 → $550.00Outperform
    BMO Capital Markets
    Workday Inc.
    $WDAY
    2/25/2026$160.00Outperform → In-line
    Evercore ISI
    Workday Inc.
    $WDAY
    2/25/2026$155.00Buy → Hold
    TD Cowen
    Workday Inc.
    $WDAY
    2/25/2026$204.00 → $182.00Outperform
    BMO Capital Markets
    Ross Stores Inc.
    $ROST
    2/25/2026$175.00 → $220.00Market Perform
    Telsey Advisory Group
    Workday Inc.
    $WDAY
    2/23/2026$150.00Buy → Hold
    Jefferies
    Workday Inc.
    $WDAY
    2/18/2026Mkt Outperform → Mkt Perform
    Citizens
    More analyst ratings

    $AKAN
    $AKTS
    $BIOR
    $BNED
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Malhotra Rohan bought $26,146 worth of Ordinary Shares (19,085 units at $1.37), increasing direct ownership by 2% to 849,642 units (SEC Form 4)

    4 - Roadzen Inc. (0001868640) (Issuer)

    3/3/26 8:00:19 AM ET
    $RDZN
    Specialty Insurers
    Finance

    Director Manning Paul B bought $2,999,996 worth of shares (550,458 units at $5.45) (SEC Form 4)

    4 - Candel Therapeutics, Inc. (0001841387) (Issuer)

    2/26/26 7:38:59 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Large owner Hrt Financial Lp bought $40,650 worth of Class A Shares (29,036 units at $1.40) and sold $10,150 worth of Class A Shares (7,868 units at $1.29) (SEC Form 4)

    4 - AKANDA CORP. (0001888014) (Issuer)

    1/20/26 2:07:19 PM ET
    $AKAN
    Medicinal Chemicals and Botanical Products
    Health Care

    $AKAN
    $AKTS
    $BIOR
    $BNED
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 6, 2023 - FDA Permits Marketing of First COVID-19 At-Home Test Using Traditional Premarket Review Process

    For Immediate Release: June 06, 2023 Today, the U.S. Food and Drug Administration granted marketing authorization for the Cue COVID-19 Molecular Test. The product is a molecular nucleic acid amplification test (NAAT) that is intended to detect genetic material from SARS-CoV-2 virus present in nasal swabs from adults with signs and symptoms of upper respiratory infection. This test is the first at-home over-the-c

    6/6/23 3:04:14 PM ET
    $HLTH
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AKAN
    $AKTS
    $BIOR
    $BNED
    SEC Filings

    View All

    Verastem Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Verastem, Inc. (0001526119) (Filer)

    3/4/26 4:15:33 PM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Verastem Inc.

    10-K - Verastem, Inc. (0001526119) (Filer)

    3/4/26 4:06:05 PM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form D filed by Sensei Biotherapeutics Inc.

    D - Sensei Biotherapeutics, Inc. (0001829802) (Filer)

    3/4/26 3:52:51 PM ET
    $SNSE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKAN
    $AKTS
    $BIOR
    $BNED
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ross Stores upgraded by Telsey Advisory Group with a new price target

    Telsey Advisory Group upgraded Ross Stores from Market Perform to Outperform and set a new price target of $240.00 from $220.00 previously

    3/4/26 8:20:36 AM ET
    $ROST
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    BMO Capital Markets reiterated coverage on Intuit with a new price target

    BMO Capital Markets reiterated coverage of Intuit with a rating of Outperform and set a new price target of $550.00 from $624.00 previously

    2/27/26 8:09:31 AM ET
    $INTU
    Computer Software: Prepackaged Software
    Technology

    Workday downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Workday from Outperform to In-line and set a new price target of $160.00

    2/25/26 7:40:49 AM ET
    $WDAY
    EDP Services
    Technology

    $AKAN
    $AKTS
    $BIOR
    $BNED
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Verastem Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Business Updates

    AVMAPKI™ FAKZYNJA™ CO-PACK net product revenues of $17.5 million for the fourth quarter of 2025 and $30.9 million for the full year 2025, following accelerated U.S. FDA approval in May 2025 Based on FDA guidance, Company to develop Phase 2 registration-directed protocols to evaluate VS-7375, a highly selective, oral KRAS G12D (ON/OFF) inhibitor with best-in-class potential, in 2L PDAC, 2L/3L NSCLC and 2L+ CRC in combination with cetuximab Cleared multiple dose levels of VS-7375 with no DLTs, continuing dose escalation to 1200 mg QD; cleared 600 mg QD dose level of VS-7375 in combination with cetuximab with no DLTs; continuing higher dose evaluations Company cash, cash equivalents, and

    3/4/26 4:01:00 PM ET
    $VSTM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NUBURU and Tekne Formalize Ukraine Industrial Deployment Platform Anchored by Operational GRAELION Units; Structured Framework Targets €80–120M Annual Program Scale

    Existing In-Country Deployments, Military-Commercialized Configuration and Kyiv Joint Office Establish Execution Baseline NUBURU, Inc. (NYSE:BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, electronic warfare and software-orchestrated defense systems, today announced that its wholly owned subsidiary, Nuburu Defense LLC, together with Tekne S.p.A. ("Tekne"), has executed a strategic cooperation agreement with Engineering Bureau "BERYL" LLC, an established Ukrainian industrial company currently producing and supplying vehicles to Ukrainian military forces, to support structured deployment of the TEKNE GRAELION platform withi

    3/4/26 7:36:00 AM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    ROSS STORES REPORTS FOURTH QUARTER EARNINGS WELL ABOVE GUIDANCE

    ANNOUNCES NEW TWO-YEAR REPURCHASE AUTHORIZATION AND 10% INCREASE IN QUARTERLY CASH DIVIDENDPROVIDES FIRST QUARTER AND FISCAL 2026 GUIDANCEDUBLIN, Calif., March 3, 2026 /PRNewswire/ -- Ross Stores, Inc. (NASDAQ:ROST) today reported financial results for the 13‑week fourth quarter and 52‑week fiscal year ended January 31, 2026. Highlights:Total sales for the fourth quarter of fiscal 2025 grew 12%, with comparable store sales increasing a robust 9%Fourth quarter operating margin of 12.3% exceeded the Company's plan of 11.5% to 11.8%, primarily from the strong sales performanceEarnings per share for the fourth quarter of $2.00 was well above guidance of $1.77 to $1.85For the full year, sales rea

    3/3/26 4:01:00 PM ET
    $ROST
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $AKAN
    $AKTS
    $BIOR
    $BNED
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Duffield David A converted options into 107,500 shares and sold $14,447,900 worth of shares (107,500 units at $134.40) (SEC Form 4)

    4 - Workday, Inc. (0001327811) (Issuer)

    3/4/26 5:38:04 PM ET
    $WDAY
    EDP Services
    Technology

    Officer Malhotra Rohan bought $26,146 worth of Ordinary Shares (19,085 units at $1.37), increasing direct ownership by 2% to 849,642 units (SEC Form 4)

    4 - Roadzen Inc. (0001868640) (Issuer)

    3/3/26 8:00:19 AM ET
    $RDZN
    Specialty Insurers
    Finance

    CEO Bhusri Aneel was granted 9,182 shares, increasing direct ownership by 2% to 587,921 units (SEC Form 4)

    4 - Workday, Inc. (0001327811) (Issuer)

    3/2/26 8:25:46 PM ET
    $WDAY
    EDP Services
    Technology

    $AKAN
    $AKTS
    $BIOR
    $BNED
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Candel Therapeutics Inc.

    SC 13G - Candel Therapeutics, Inc. (0001841387) (Subject)

    12/17/24 12:30:40 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13D/A filed by Nuburu Inc.

    SC 13D/A - Nuburu, Inc. (0001814215) (Subject)

    11/25/24 8:59:19 PM ET
    $BURU
    Industrial Machinery/Components
    Miscellaneous

    Amendment: SEC Form SC 13G/A filed by Blue Star Foods Corp.

    SC 13G/A - Blue Star Foods Corp. (0001730773) (Subject)

    11/14/24 7:34:10 PM ET
    $BSFC

    $AKAN
    $AKTS
    $BIOR
    $BNED
    Financials

    Live finance-specific insights

    View All

    ROSS STORES REPORTS FOURTH QUARTER EARNINGS WELL ABOVE GUIDANCE

    ANNOUNCES NEW TWO-YEAR REPURCHASE AUTHORIZATION AND 10% INCREASE IN QUARTERLY CASH DIVIDENDPROVIDES FIRST QUARTER AND FISCAL 2026 GUIDANCEDUBLIN, Calif., March 3, 2026 /PRNewswire/ -- Ross Stores, Inc. (NASDAQ:ROST) today reported financial results for the 13‑week fourth quarter and 52‑week fiscal year ended January 31, 2026. Highlights:Total sales for the fourth quarter of fiscal 2025 grew 12%, with comparable store sales increasing a robust 9%Fourth quarter operating margin of 12.3% exceeded the Company's plan of 11.5% to 11.8%, primarily from the strong sales performanceEarnings per share for the fourth quarter of $2.00 was well above guidance of $1.77 to $1.85For the full year, sales rea

    3/3/26 4:01:00 PM ET
    $ROST
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Intuit Reports Strong Second-Quarter Results and Reiterates Full-Year Guidance

    Global Business Solutions Online Ecosystem Revenue Grew 21 percent; Consumer Revenue Grew 15 percent Intuit Inc. (NASDAQ:INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, Mailchimp, and Intuit Enterprise Suite, announced financial results for the second quarter of fiscal 2026, which ended January 31. "We delivered an outstanding second quarter, driven by disciplined execution," said Sasan Goodarzi, chairman and chief executive officer of Intuit. "We are defining a new category at the intersection of AI and human intelligence, one that delivers autonomous, done-for-you experiences, disrupts the traditional assisted tax segment, and pro

    2/26/26 4:00:00 PM ET
    $INTU
    Computer Software: Prepackaged Software
    Technology

    Workday Announces Fiscal 2026 Fourth Quarter and Full Year Financial Results

    Fiscal Fourth Quarter Total Revenues of $2.532 Billion, Up 14.5% Year-Over-YearSubscription Revenues of $2.360 Billion, Up 15.7% Year-Over-YearFiscal Year 2026 Total Revenues of $9.552 Billion, Up 13.1% Year-Over-YearSubscription Revenues of $8.833 Billion, Up 14.5% Year-Over-YearOperating Cash Flows of $2.939 Billion, Up 19.4% Year-Over-YearPLEASANTON, Calif., Feb. 24, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced results for the fiscal 2026 fourth quarter and full year ended January 31, 2026. Fiscal 2026 Fourth Quarter ResultsTotal revenues were $2.532 billion, an increase of

    2/24/26 4:01:00 PM ET
    $WDAY
    EDP Services
    Technology

    $AKAN
    $AKTS
    $BIOR
    $BNED
    Leadership Updates

    Live Leadership Updates

    View All

    Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter

    Carl Eschenbach Steps Down After Leading Company Through a Period of Global Expansion and Operational Scale Company Reaffirms Fiscal 2026 Fourth Quarter and Full-Year Outlook PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced that co-founder and current executive chair Aneel Bhusri is returning as chief executive officer as the company enters its next chapter, focused on leading in the rapidly evolving AI era. Carl Eschenbach is stepping down as CEO and as a member of the board after leading Workday through a period defined by global growth, an expanded industry focus, and strengthen

    2/9/26 8:30:00 AM ET
    $WDAY
    EDP Services
    Technology

    Workiva Announces Two New Appointments to Board of Directors

    Company Appoints Former Cisco and Autodesk CFO Scott Herren and Former Workday Co-President, CFO, and EVP Mark Peek Workiva Inc. (NYSE:WK), a leading, AI-powered platform for trust, transparency, and accountability, today announced the appointment of two new independent directors to its Board of Directors. Scott Herren is the former EVP and Chief Financial Officer of Cisco and current Board member and Audit Committee Chair at Rubrik (NYSE:RBRK). Mark Peek is a former EVP, CFO, and Co-President of Workday (NASDAQ:WDAY) and currently sits on the Board of Directors for SentinelOne (NYSE:S) and Trimble (NASDAQ:TRMB). "We are pleased to welcome two highly experienced SaaS leaders to our Boar

    1/28/26 4:05:00 PM ET
    $RBRK
    $S
    $TRMB
    Computer Software: Prepackaged Software
    Technology
    Industrial Machinery/Components
    Industrials

    Workday to Invest CAD $1 Billion in Canada Over Five Years

    Investment to Fuel the Growth of Workday's Canadian Business and Support Workday's Rapidly Growing Canadian Customer Base Company Joins With Glowing Hearts Reservist Registry as Part of Ongoing Efforts to Support Local Communities in Canada PLEASANTON, Calif., Jan. 20, 2026 /PRNewswire/ -- Workday, Inc.  (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced its plans to invest CAD $1 billion in Canada over the next five years. The multi-year investment demonstrates Workday's commitment to growing in Canada, including plans to further develop local tech talent, strengthen local customer support, and give back to Canadian communities through particip

    1/20/26 8:00:00 AM ET
    $WDAY
    EDP Services
    Technology